(Q43450874)

23 November 2017

title

Comparison of daily and alternate-day prednisone during chronic maintenance therapy: a controlled crossover study (English)

1 reference

23 November 2017

Curtis JJ

1

1 reference

23 November 2017

Galla JH

2

1 reference

23 November 2017

Woodford SY

3

1 reference

23 November 2017

Saykaly RJ

4

1 reference

23 November 2017

Luke RG

5

1 reference

23 November 2017

publication date

1 November 1981

1 reference

American Journal of Kidney Diseases

23 November 2017

published in

1 reference

23 November 2017

volume

1

1 reference

23 November 2017

issue

3

1 reference

23 November 2017

page(s)

166-171

1 reference

Alternate-day corticosteroid therapy

23 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Benefit from alternate-day prednisone in myasthenia gravis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day steroid regimen in the treatment of ocular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Treatment of the nephrotic syndrome in childhood. Use of an alternate-day prednisone regimen

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate day steroid therapy in diffuse pulmonary sarcoidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day steroid therapy in lupus nephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day prednisone therapy for pemphigus vulgaris. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Cyclophosphamide-induced remissions in advanced polyarteritis nodosa

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Effect of alternate-day steroids on renal transplant function. A controlled study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Editorial: alternate-day prednisone therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Hyperlipidemia in adult, pediatric and diabetic renal transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day prednisone therapy. Evaluation of delayed hypersensitivity responses, control of disease and steroid side effects.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

STUDIES ON AN INTERMITTENT CORTICOSTEROID DOSAGE REGIMEN

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Adrenocortical Responsiveness after Alternate-Day Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Adrenocortical Function During Intermittent Corticosteroid Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Pituitary adrenal function during corticosteroid withdrawal in rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Drug spotlight program: systemic corticosteroid therapy: pharmacology and endocrinologic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Reduction of toxicity of corticosteroid therapy after renal transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day single-dose prednisone therapy: A method of reducing steroid toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

The effect of alternate-day prednisone on the white blood count in children with chronic asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

The Effect of In Vivo Hydrocortisone on Subpopulations of Human Lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day prednisone therapy in recipients of renal allografts. Risk and benefits

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

Alternate-day therapy with methylprednisolone after renal transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2881%2980023-6

7 January 2021

10.1016/S0272-6386(81)80023-6

Identifiers

DOI

1 reference

23 November 2017

1 reference